Back to Interventions
Substance / Medication

Ceftizoxime

SNOMED 372770006UMLS C0007560

Overview

Active Ingredient
ceftizoxime
RxNorm CUI
2192

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Infection caused by Bacteroides
Gonorrhea
Haemophilus infection
Bacterial pneumonia
Staphylococcal infectious disease
Pseudomonas infection
Urinary tract infectious disease
Colibacillosis
Bacterial infection caused by Serratia
Streptococcal infectious disease
Bacterial infectious disease
Soft tissue infection
Bacterial meningitis
Bacterial infection of skin
Proteus infection
Female pelvic inflammation
Infection caused by Klebsiella
Acinetobacter infection

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

1 trials linked to this intervention

1
Total Trials
0
Recruiting
0
With Results

Recent Trials

Prophylactic Ceftizoxime (Cefizox) for Elective Cesarean Delivery

NCT01347593Phase 4Completed220 enrolled
View all 1 trials on ClinicalTrials.gov

Research Evidence

Published studies and systematic reviews

Sort:
Prophylactic ceftizoxime for elective cesarean delivery at Soba Hospital, Sudan.
Osman Bashier, Abbas Amna, Ahmed Mohamed A et al. · BMC Res Notes · 2013
PMID: 23394621RCTFull text (PMC)
Is ceftizoxime an appropriate surrogate for amikacin in neonatal sepsis treatment? A randomized clinical trial.
Taheri Peymaneh Alizadeh, Eslamieh Hossein, Salamati Peyman · Acta Med Iran · 2011
PMID: 22009803RCT
Influence of biomaterials on scintigraphic diagnosis of periprosthetic infections. Ceftizoxime-99m technetium model.
Teixeira Luiz Eduardo Moreira, Pádua Bruno Jannotti, Castilho André Moreira et al. · Acta Cir Bras · 2018
PMID: 29412229Observational
[Comparison of oxacillin, cefoxitin, ceftizoxime, and moxalactam disk diffusion methods for detection of methicillin susceptibility in staphylococci].
Özel Gönül, Aslan Volkan, Bahar Erdem Gül et al. · Mikrobiyol Bul · 2011
PMID: 21644068Observational
Simultaneous determination of cefazolin or ceftizoxime in presence of ascorbic acid from pharmaceutical formulation and human serum by RP-HPLC.
Arayne M Saeed, Sultana Najma, Bi Bi Zakia · Pak J Pharm Sci · 2007
PMID: 17337430Observational
Comparative study of the effects of ceftizoxime, piperacillin, and piperacillin-tazobactam concentrations on antibacterial activity and selection of antibiotic-resistant mutants of Enterobacter cloacae and Bacteroides fragilis in vitro and in vivo in mixed-infection abscesses.
Stearne Lorna E T, van Boxtel Doret, Lemmens Nicole et al. · Antimicrob Agents Chemother · 2004
PMID: 15105122ObservationalFull text (PMC)
Markedly elevated procalcitonin in ceftizoxime-induced drug fever.
Wei Yanhua, Fu Yan, Cheng Manman et al. · Asian J Surg · 2024
PMID: 38521745Case Report
Case report: Decreased hemoglobin and multiple organ failure caused by ceftizoxime-induced immune hemolytic anemia in a Chinese patient with malignant rectal cancer.
Lou Can, Liu Meng, Ma Ting et al. · Front Immunol · 2024
PMID: 38756782Case ReportFull text (PMC)
Eggerthella lenta bacteremia successfully treated with ceftizoxime: case report and review of the literature.
Jiang Shuming, E Jianfei, Wang Dengchao et al. · Eur J Med Res · 2021
PMID: 34544476Case ReportFull text (PMC)
Marked reduction in haemoglobin levels secondary to ceftizoxime-induced immune haemolytic anaemia in diabetic patients.
Wu Shengjie, Jing Li, Feng Yipeng et al. · J Clin Pharm Ther · 2020
PMID: 32319116Case Report

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ceftizoxime (substance)
SNOMED CT
372770006
UMLS CUI
C0007560
RxNorm CUI
2192

Clinical Data

This intervention maps to 18 entities in the Ltrl knowledge graph.

18
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
1
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.